• Explore /
  • Poster
  • / A novel small molecule inhibitor of p300/CBP for the treatment of castration-resistant prostate cancer: Preclinical evaluation.

A novel small molecule inhibitor of p300/CBP for the treatment of castration-resistant prostate cancer: Preclinical evaluation.

Abstract Poster

Authors

null

Nigel Brooks

CellCentric Ltd, Cambridge, United Kingdom

Nigel Brooks , Neil Pegg , Jenny Worthington , Barbara Young , Amy Prosser , Jordan Lane , David Taddei , Matthew Joseph Schiewer , Nicolas Gordon , Karen E. Knudsen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 168)

DOI

10.1200/JCO.2017.35.6_suppl.168

Abstract #

168

Poster Bd #

F22

Abstract Disclosures

Similar Posters

First Author: Neil Pegg

Poster

2023 ASCO Genitourinary Cancers Symposium

<span>Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.</span>

Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.

First Author: Amy K Taylor

First Author: Giorgia Gurioli

First Author: Di Maria Jiang